Cue Biopharma (CUE) Shares Outstanding (2017 - 2025)

Cue Biopharma has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $3.2 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 56.3% year-over-year to $3.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 million (up 56.3% YoY) and the FY2025 annual result came in at $3.2 million, up 56.3% from the prior year.
• Shares Outstanding (Entity) retreated to $3.2 million in Q4 2025 per CUE's latest filing, from $3.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $3.4 million in Q3 2025 and troughed at $1.0 million in Q1 2021.
• A 5-year average of $1.7 million and a median of $1.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Entity) rose 4.56% in 2021, then jumped 67.54% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $1.1 million in 2021, then increased by 10.7% to $1.2 million in 2022, then surged by 32.44% to $1.6 million in 2023, then jumped by 30.93% to $2.1 million in 2024, then jumped by 56.3% to $3.2 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $3.2 million, $3.4 million, and $2.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.